We are live on
!
Find out more
YIH
Y-Intercept (HK) Portfolio holdings
AUM
$5.05B
1-Year Est. Return
17.89%
This Fund
S&P 500
This Quarter
Est. Return
+8.69%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
–
AUM
$393M
AUM Growth
+$20.1M
(+5.4%)
Cap. Flow
+$9.32M
Cap. Flow
% of AUM
2.37%
Top 10 Holdings %
Top 10 Hldgs %
14.62%
Holding
983
New
387
Increased
109
Reduced
91
Closed
395
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$12.3M |
| 2 |
Moderna
MRNA
|
+$5.95M |
| 3 |
Qualcomm
QCOM
|
+$4.24M |
| 4 |
TAL Education Group
TAL
|
+$3.82M |
| 5 |
Advanced Micro Devices
AMD
|
+$3.65M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$3.44M |
| 2 |
Kimberly-Clark
KMB
|
+$2.7M |
| 3 |
Moody's
MCO
|
+$2.68M |
| 4 |
United Parcel Service
UPS
|
+$2.64M |
| 5 |
Sherwin-Williams
SHW
|
+$2.59M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.91% |
| 2 | Technology | 17.83% |
| 3 | Consumer Discretionary | 11.15% |
| 4 | Industrials | 9.32% |
| 5 | Materials | 8.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Bausch Health
BHC
$1.67B
| – | – |
-12,499
| Closed | -$490K |
|
627
BHP
BHP
$213B
| – | – |
-16,992
| Closed | -$1.06M |
|
|
628
Baidu
BIDU
$35.8B
| – | – |
-15,753
| Closed | -$3.44M |
|
629
Bio-Rad Laboratories Class A
BIO
$8.47B
| – | – |
-585
| Closed | -$330K |
|
630
Black Hills Corp
BKH
$5.68B
| – | – |
-4,059
| Closed | -$271K |
|
631
BlackLine
BL
$1.8B
| – | – |
-3,349
| Closed | -$350K |
|
|
BLDP
632
Ballard Power Systems
BLDP
$865M
| – | – |
-52,126
| Closed | -$1.41M |
|
633
Blackrock
BLK
$165B
| – | – |
-1,512
| Closed | -$1.13M |
|
634
Badger Meter
BMI
$3.71B
| – | – |
-3,224
| Closed | -$304K |
|
635
Box
BOX
$4.18B
| – | – |
-10,087
| Closed | -$232K |
|
636
British American Tobacco
BTI
$131B
| – | – |
-43,084
| Closed | -$1.66M |
|
637
AB InBev
BUD
$156B
| – | – |
-5,730
| Closed | -$367K |
|
638
Beyond Meat
BYND
$283M
| – | – |
-1,909
| Closed | -$241K |
|
639
Credit Acceptance
CACC
$5.78B
| – | – |
-597
| Closed | -$224K |
|
640
Conagra Brands
CAG
$7.29B
| – | – |
-25,090
| Closed | -$961K |
|
641
Cardinal Health
CAH
$53.7B
| – | – |
-13,068
| Closed | -$814K |
|
642
Calix
CALX
$2.32B
| – | – |
-6,114
| Closed | -$204K |
|
643
Avis
CAR
$5.78B
| – | – |
-4,899
| Closed | -$367K |
|
644
CarGurus
CARG
$3.15B
| – | – |
-12,719
| Closed | -$304K |
|
645
Cboe Global Markets
CBOE
$30.2B
| – | – |
-9,142
| Closed | -$889K |
|
646
Chemours
CC
$2.55B
| – | – |
-8,178
| Closed | -$227K |
|
647
Carnival Corporation Ltd
CCL
$37.1B
| – | – |
-9,979
| Closed | -$266K |
|
648
Cogent Communications
CCOI
$612M
| – | – |
-3,919
| Closed | -$264K |
|
649
CareDx
CDNA
$1.88B
| – | – |
-8,734
| Closed | -$550K |
|
650
Celsius Holdings
CELH
$7.36B
| – | – |
-20,670
| Closed | -$315K |
|
Similar funds
HSA
O
LIM
LFG
JIM
CTC
NL
BPWM
Y-Intercept (HK)'s Q2 2021 Portfolio in Review
As of Q2 2021, Y-Intercept (HK) held 983 positions worth $393M, up 5.4% from $373M the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Y-Intercept (HK)'s Q2 2021 filing shows 387 new, 109 increased, 91 reduced and 395 closed positions. Its largest new stake was Linde: 42,339 shares worth $12.2M. The largest sale was Baidu, an estimated $3.44M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Discretionary.
- Y-Intercept (HK)'s largest Q2 2021 buy was Linde: 42,339 shares worth $12.2M.
- Y-Intercept (HK) added most to Moderna in Q2 2021, an estimated $5.95M increase.
- Y-Intercept (HK)'s biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $2.59M.
- Y-Intercept (HK) fully exited Baidu in Q2 2021, selling an estimated $3.44M.
- Y-Intercept (HK)'s ten largest holdings make up 15% of its $393M portfolio in Q2 2021.
- Y-Intercept (HK) opened 387 new positions and closed 395 in Q2 2021.
- Y-Intercept (HK)'s portfolio value rose 5.4% quarter-over-quarter to $393M.
Based on Y-Intercept (HK)'s 13F filing for Q2 2021, filed 12 Aug 2021.